ANI Pharmaceuticals
ANIP
ANIP
120 hedge funds and large institutions have $293M invested in ANI Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 52 increasing their positions, 33 reducing their positions, and 16 closing their positions.
Holders
120
Holders Change
-6
Holders Change %
-4.76%
% of All Funds
2.03%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
13
Increased
52
Reduced
33
Closed
16
Calls
$614K
Puts
$1.86M
Net Calls
-$1.25M
Net Calls Change
+$134K
Top Buyers
1 |
ACM
1
AIGH Capital Management
Baltimore,
Maryland
|
$7.25M |
2 |
KCM
2
Kennedy Capital Management
St Louis,
Missouri
|
$4.81M |
3 |
3
BlackRock
New York
|
$58.7M |
4 |
4
Goldman Sachs
New York
|
$4.03M |
5 |
EA
5
Emerald Advisers
Leola,
Pennsylvania
|
$13.5M |